Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
World J Surg ; 36(7): 1562-70, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22402976

RESUMO

INTRODUCTION: The distribution of survival times after injury has been described as "trimodal," but several studies have not confirmed this. The purpose of this study was to clarify the distribution of survival times after injury. METHODS: We defined survival time (t(s)) as the interval between injury time and declared death time. We constructed histograms for t(s) ≤ 150 min from the 2004-2007 Fatality Analysis Reporting System (FARS, for traffic crashes) and National Violent Death Reporting System (NVDRS, for homicides). We estimated statistical models in which death times known only within intervals were treated as interval-censored. For confirmation, we also obtained EMS response times (t(r)), prehospital times (t(p)), and hospital times (t(h)) for decedents in the 2008 National Trauma Data Bank (NTDB) with t(s) = t(p) + t(h) ≤ 150. We approximated times until circulatory arrest (t(x)) as t(r) for patients pulseless at the injury scene, t(p) for other patients pulseless at hospital admission, and t(s) for the rest; for any declared t(s), we calculated mean t(x)/t(s). We used this ratio to estimate t(x) for hospital deaths in FARS or NVDRS and provide independent support for using interval-censored methods. RESULTS: FARS and NVDRS deaths were most frequent in the first few minutes. Both showed a second peak at 35-40 min after injury, corresponding to peaks in hospital deaths. Third peaks were not present. Estimated t(x) in FARS and NVDRS did not show second peaks and were similar to estimates treating some death times as interval-censored. CONCLUSIONS: Increases in frequency of survival times at 35-40 min are primarily artifacts created because declaration of death in hospitals is delayed until completing resuscitative attempts. By avoiding these artifacts, interval censoring methods are useful for analysis of injury survival times.


Assuntos
Acidentes de Trânsito/mortalidade , Homicídio/estatística & dados numéricos , Suicídio/estatística & dados numéricos , Ferimentos e Lesões/mortalidade , Acidentes de Trânsito/estatística & dados numéricos , Causas de Morte , Serviços Médicos de Emergência , Mortalidade Hospitalar , Humanos , Análise de Sobrevida , Fatores de Tempo , Estados Unidos/epidemiologia
2.
J Surg Educ ; 77(6): e196-e200, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32843317

RESUMO

OBJECTIVE: To assess the association between level of resident autonomy and operative times for appendectomies. DESIGN: A single center retrospective analysis of electronic medical record data of patients who underwent an appendectomy from 1/1/2017 to 12/31/2018. Medical record numbers s were matched with cases entered in the ACGME Resident Case Log system. Cases were stratified by resident role ("First Assistant," "Surgeon Junior," "Surgeon Chief," or "Teaching Assistant") and operative times were compared to cases without resident participation using student's t test. SETTING: Maine Medical Center, Department of Surgery, Portland, Maine. PARTICIPANTS: Inclusion criteria: ≥5 years old, underwent appendectomy at a tertiary medical center during the study duration, and either had corresponding Case-log data or had no resident involvement. Patients who underwent appendectomy as part of a larger procedure were excluded. RESULTS: Six hundred eighty-eight patients met inclusion criteria, with residents participating in 574 (83.5%) cases. Overall mean operating time was 51 ± 21.5 minutes. Attending physicians without resident participation had the shortest OR times (43 ± 19.1 minutes). There was no difference in operating time between chief resident involvement and attending physicians without resident participation (45 ± 21; p = 0.43). Cases with residents involved as "First Assistant" (53 ± 18.6 minutes; p = 0.04) "Surgeon Junior" (52 ± 24.0 minutes; p < 0.001), or "Teaching Assistant" (57 ± 21.6 minutes; p < 0.001) were found to have longer operating times as compared to attending physicians operating without a resident. CONCLUSIONS: Operative times for appendectomies are impacted by resident role. Chief residents' operative times approach that of attendings when operating as Surgeon Chief, however they are significantly longer when operating as Teaching Assistant. Involvement of junior residents in any role lengthen operating times. This suggests that surgical education influences operating room efficiency.


Assuntos
Cirurgia Geral , Internato e Residência , Apendicectomia , Pré-Escolar , Competência Clínica , Cirurgia Geral/educação , Humanos , Duração da Cirurgia , Estudos Retrospectivos
3.
Inj Epidemiol ; 5(1): 11, 2018 Apr 09.
Artigo em Inglês | MEDLINE | ID: mdl-29629480

RESUMO

BACKGROUND: The article introduces Programs for Injury Categorization, using the International Classification of Diseases (ICD) and R statistical software (ICDPIC-R). Starting with ICD-8, methods have been described to map injury diagnosis codes to severity scores, especially the Abbreviated Injury Scale (AIS) and Injury Severity Score (ISS). ICDPIC was originally developed for this purpose using Stata, and ICDPIC-R is an open-access update that accepts both ICD-9 and ICD-10 codes. METHODS: Data were obtained from the National Trauma Data Bank (NTDB), Admission Year 2015. ICDPIC-R derives CDC injury mechanism categories and an approximate ISS ("RISS") from either ICD-9 or ICD-10 codes. For ICD-9-coded cases, RISS is derived similar to the Stata package (with some improvements reflecting user feedback). For ICD-10-coded cases, RISS may be calculated in several ways: The "GEM" methods convert ICD-10 to ICD-9 (using General Equivalence Mapping tables from CMS) and then calculate ISS with options similar to the Stata package; a "ROCmax" method calculates RISS directly from ICD-10 codes, based on diagnosis-specific mortality in the NTDB, maximizing the C-statistic for predicting NTDB mortality while attempting to minimize the difference between RISS and ISS submitted by NTDB registrars (ISSAIS). Findings were validated using data from the National Inpatient Survey (NIS, 2015). RESULTS: NTDB contained 917,865 cases, of which 86,878 had valid ICD-10 injury codes. For a random 100,000 ICD-9-coded cases in NTDB, RISS using the GEM methods was nearly identical to ISS calculated by the Stata version, which has been previously validated. For ICD-10-coded cases in NTDB, categorized ISS using any version of RISS was similar to ISSAIS; for both NTDB and NIS cases, increasing ISS was associated with increasing mortality. Prediction of NTDB mortality was associated with C-statistics of 0.81 for ISSAIS, 0.75 for RISS using the GEM methods, and 0.85 for RISS using the ROCmax method; prediction of NIS mortality was associated with C-statistics of 0.75-0.76 for RISS using the GEM methods, and 0.78 for RISS using the ROCmax method. Instructions are provided for accessing ICDPIC-R at no cost. CONCLUSIONS: The ideal methods of injury categorization and injury severity scoring involve trained personnel with access to injured persons or their medical records. ICDPIC-R may be a useful substitute when this ideal cannot be obtained.

4.
Behav Neurosci ; 119(1): 265-79, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15727531

RESUMO

Salts are transduced by at least 2 mechanisms: (a) antagonized by amiloride and (b) antagonized by cetylpyridinium chloride (CPC). The authors report on 4 behavioral experiments in rats that characterize the orosensory properties of CPC itself as well as its effect in suppressing the intensity of NaCl and KCl taste. Experiments 1 and 2 indicated that CPC has a quinine-like taste quality. Experiments 3 and 4 demonstrated that the recognition of KCl, but not NaCl, is modestly reduced by mixture with CPC. However, control experiments call into question the mechanism of the salt suppression of CPC, because both CPC-salt and quinine-salt mixtures had similar effects. The relevance of these studies for understanding salt and bitter taste coding is discussed.


Assuntos
Cetilpiridínio/farmacologia , Detergentes/farmacologia , Cloreto de Sódio/farmacologia , Paladar/fisiologia , Animais , Antimaláricos/farmacologia , Dieta , Masculino , Quinina/farmacologia , Ratos , Ratos Sprague-Dawley , Reconhecimento Psicológico
5.
J Burn Care Res ; 33(3): 347-53, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22002206

RESUMO

The aim of this study is to quantify the changes in incidence, severity, and mortality in burn injuries in the state of Maine over the past 50 years from both prevention and treatment perspectives. The authors analyzed the data from multiple sources, including the U.S. Census, death certificates, hospital discharge abstracts, and institutional burn registries in Maine and Boston. The average annual number of burn-related deaths decreased from 53 in 1960-1964 to 14 in 2004-2008. The Maine age-adjusted rate of burn deaths was 8.6% above the national rate in 1960 and 1.4% below it in 2006. The annual number of burn patients admitted to Maine hospitals declined by 65% from 1978 to 2009. Since 1999, 12% of hospitalized patients in Maine were treated in an American Burn Association-certified burn center in Boston. Mortality for Maine burn patients, including those treated at Boston hospitals, is directly related to age and burn severity and similar to stratified mortality in the National Burn Repository. Incidence, severity, and mortality of burn injuries in Maine have decreased dramatically over the past 5 decades. Prevention programs, legislation, and a regionalized system of burn care have all likely contributed to bringing Maine's morbidity and mortality rate below the national average.


Assuntos
Unidades de Queimados/estatística & dados numéricos , Queimaduras/epidemiologia , Causas de Morte , Adolescente , Adulto , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Boston/epidemiologia , Queimaduras/prevenção & controle , Queimaduras/terapia , Criança , Terapia Combinada , Bases de Dados Factuais , Feminino , Humanos , Incidência , Escala de Gravidade do Ferimento , Maine/epidemiologia , Masculino , Pessoa de Meia-Idade , Prevenção Primária/organização & administração , Estudos Retrospectivos , População Rural , Distribuição por Sexo , Análise de Sobrevida , População Urbana , Adulto Jovem
6.
J Clin Invest ; 119(11): 3437-49, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19841542

RESUMO

Activated protein C (APC) is a signaling protease with anticoagulant activity. Here, we have used mice expressing a mutation in superoxide dismutase-1 (SOD1) that is linked to amyotrophic lateral sclerosis (ALS) to show that administration of APC or APC analogs with reduced anticoagulant activity after disease onset slows disease progression and extends survival. A proteolytically inactive form of APC with reduced anticoagulant activity provided no benefit. APC crossed the blood-spinal cord barrier in mice via endothelial protein C receptor. When administered after disease onset, APC eliminated leakage of hemoglobin-derived products across the blood-spinal cord barrier and delayed microglial activation. In microvessels, motor neurons, and microglial cells from SOD1-mutant mice and in cultured neuronal cells, APC transcriptionally downregulated SOD1. Inhibition of SOD1 synthesis in neuronal cells by APC required protease-activated receptor-1 (PAR1) and PAR3, which inhibited nuclear transport of the Sp1 transcription factor. Diminished mutant SOD1 synthesis by selective gene excision within endothelial cells did not alter disease progression, which suggests that diminished mutant SOD1 synthesis in other cells, including motor neurons and microglia, caused the APC-mediated slowing of disease. The delayed disease progression in mice after APC administration suggests that this approach may be of benefit to patients with familial, and possibly sporadic, ALS.


Assuntos
Fibrinolíticos/farmacologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Microglia/enzimologia , Neurônios Motores/enzimologia , Proteína C/farmacologia , Superóxido Dismutase/metabolismo , Esclerose Lateral Amiotrófica/tratamento farmacológico , Animais , Barreira Hematoencefálica/metabolismo , Linhagem Celular , Núcleo Celular/metabolismo , Células Cultivadas , Modelos Animais de Doenças , Endotélio/metabolismo , Fibrinolíticos/uso terapêutico , Masculino , Camundongos , Microglia/citologia , Fármacos Neuroprotetores/farmacologia , Fármacos Neuroprotetores/uso terapêutico , Proteína C/uso terapêutico , Receptores de Superfície Celular/metabolismo , Receptores Ativados por Proteinase/metabolismo , Fator de Transcrição Sp1/metabolismo , Medula Espinal/irrigação sanguínea , Medula Espinal/enzimologia , Superóxido Dismutase/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA